Osaic Holdings
ARTV

Osaic Holdings’s Artiva Biotherapeutics ARTV Stock Holding History

Osaic Holdings’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$116 Sell
18
-14
-44% -$69 ﹤0.01% 7619
2025
Q4 		$137 Buy
+32
New +$121 ﹤0.01% 7619

Other funds holding ARTV

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $67.4M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Osaic Holdings's ARTV Position: Q1 2026 in Review

Osaic Holdings reduced its Artiva Biotherapeutics (ARTV) stake by 44% in Q1 2026, selling an estimated $69 and leaving 18 shares worth $116. The position accounts for ﹤0.01% of the portfolio, ranked #7619.

Osaic Holdings first reported a position in ARTV in Q4 2025 and has held it in 2 quarters since. The position peaked at $137 in Q4 2025. 40 funds tracked by Wall St. Rank hold ARTV as of Q1 2026.

  • Osaic Holdings held 18 shares of Artiva Biotherapeutics worth $116 as of Q1 2026.
  • Osaic Holdings sold 14 Artiva Biotherapeutics shares in Q1 2026, an estimated $69.
  • Artiva Biotherapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7619 holding.
  • Osaic Holdings first reported a position in Artiva Biotherapeutics in Q4 2025 and has held it in 2 quarters since.
  • Osaic Holdings's Artiva Biotherapeutics position peaked at $137 in Q4 2025.
  • 40 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.